Valuation: MiniMed Group, Inc.

Market Cap 5.74B 4.92B 4.6B 4.21B 7.91B 550B 8.01B 54.39B 21.21B 276B 21.57B 21.1B 913B P/E 2027 *
32.7x
P/E 2028 * 32.2x
Enterprise Value 5.35B 4.58B 4.29B 3.93B 7.37B 512B 7.46B 50.67B 19.76B 257B 20.09B 19.65B 851B EV / Sales 2027 *
1.56x
EV / Sales 2028 * 1.39x
Free-Float
9.28%
Yield 2027 *
-
Yield 2028 * -
1 day+1.34%
1 week+1.49%
Current month+13.30%
1 month+25.23%
3 months+72.28%
1 week 19.19
Extreme 19.1875
20.84
1 month 16.25
Extreme 16.25
20.88
Current year 10.65
Extreme 10.65
20.88
1 year 10.65
Extreme 10.65
20.88
3 years 10.65
Extreme 10.65
20.88
5 years 10.65
Extreme 10.65
20.88
10 years 10.65
Extreme 10.65
20.88
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%+1.49% - - 5.74B
Average +1.34%
Weighted average by Cap. +1.34%

Financials

2027 *2028 *
Net sales 3.42B 2.93B 2.74B 2.51B 4.71B 327B 4.77B 32.41B 12.64B 164B 12.85B 12.57B 544B 3.71B 3.18B 2.97B 2.72B 5.11B 355B 5.18B 35.13B 13.7B 178B 13.93B 13.63B 590B
Net income 175M 150M 140M 128M 241M 16.75B 244M 1.66B 646M 8.41B 657M 643M 27.83B 207M 178M 166M 152M 285M 19.83B 289M 1.96B 765M 9.96B 778M 761M 32.95B
Net Debt -393M -336M -315M -288M -541M -37.57B -548M -3.72B -1.45B -18.87B -1.47B -1.44B -62.42B -601M -515M -481M -441M -827M -57.47B -838M -5.69B -2.22B -28.87B -2.26B -2.21B -95.5B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-21 US$20.45 +1.34% 1,119,136
26-08-20 US$20.18 -0.20% 1,424,528
26-08-19 US$20.22 +4.44% 1,619,385
26-08-18 US$19.36 -0.87% 1,501,753
26-08-17 US$19.53 -3.08% 1,516,423
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
20.45USD
Average target price
20.83USD
Spread / Average Target
+1.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock